Spyre Therapeutics Inc. Free Cash Flow Generation Index
Latest as of June 2021:
0.99x
Spyre Therapeutics Inc. free cash flow generation index. Spyre Therapeutics Inc. (SYRE) has a Free Cash Flow Generation Index of 0.99x as of June 2021. Free cash flow of $2.05 Million represents 1% of operating cash flow ($2.08 Million).
FCF Generation Index
0.99x
Free Cash Flow / Operating CF
Free Cash Flow
$2.05 Million
USD
Operating Cash Flow
$2.08 Million
USD
Capital Expenditures
$30.00K
USD
Spyre Therapeutics Inc. Free Cash Flow Generation Index by Year (None–None)
Spyre Therapeutics Inc. free cash flow generation index by year from None to None. Year-by-year Free Cash Flow Generation Index for Spyre Therapeutics Inc.. For the full cash flow conversion analysis, see SYRE cash flow conversion.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).